Kelly Lawrence W & Associates’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,200
Closed -$70K 135
2018
Q1
$70K Hold
1,200
0.01% 109
2017
Q4
$66K Sell
1,200
-126,600
-99% -$6.46M 0.01% 113
2017
Q3
$6.5M Buy
127,800
+9,700
+8% +$519K 1.24% 30
2017
Q2
$6.85M Buy
118,100
+23,700
+25% +$1.38M 1.35% 31
2017
Q1
$5.52M Buy
94,400
+49,400
+110% +$2.8M 1.14% 32
2016
Q4
$2.5M Buy
+45,000
New +$2.41M 0.55% 40

Other funds holding ALKS

Kelly Lawrence W & Associates's ALKS Position: Q2 2018 in Review

Kelly Lawrence W & Associates sold out of Alkermes (ALKS) in Q2 2018, closing a stake of 1,200 shares — an estimated $70K sold.

Kelly Lawrence W & Associates first reported a position in ALKS in Q4 2016 and held it in 6 quarters. The position peaked at $6.85M in Q2 2017. 244 funds tracked by Wall St. Rank hold ALKS as of Q2 2018.

  • Kelly Lawrence W & Associates reported no remaining Alkermes position as of Q2 2018 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 1,200 Alkermes shares in Q2 2018, an estimated $70K.
  • Kelly Lawrence W & Associates first reported a position in Alkermes in Q4 2016 and held it in 6 quarters.
  • Kelly Lawrence W & Associates's Alkermes position peaked at $6.85M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Alkermes as of Q2 2018.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.